Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Navigating Prior Authorization in Dermatology
Description
The presentation discusses the complexities and challenges associated with prior authorization (PA) in dermatology, emphasizing its role as a cost control mechanism implemented by health insurance plans, which often delays patient care and adds to the administrative burden on healthcare providers. The speaker highlights how PA requirements, increasingly tied to step therapy, force practitioners to begin treatment with cheaper options before accessing more effective but expensive alternatives. Various studies reveal significant inefficiencies, reporting that PAs can take substantial time to process, costing practices both financially and in terms of physician morale, leading to burnout and impacting patient treatment outcomes. Advocacy efforts by the American Academy of Dermatology (AAD) are noted, as they work towards streamlining PA processes and pushing for legislative changes to ease the burden on providers. Tools and resources provided by the AAD to assist dermatologists with the PA process are highlighted, including appeal letter templates and survey data on patient care. The presentation concludes by reiterating the negative impact of PAs on patient health and healthcare provider satisfaction, while emphasizing the importance of collective advocacy to drive change.
View moreConclusions
- Prior authorizations can significantly delay patient care and lead to harm.
- The complexity of prior authorization processes contributes to physician burnout and low morale.
- Patients often experience lapses in treatment due to the burdens of prior authorization requirements.
- Brand-name and biologic medications face the highest burden of prior authorization.
- Legislation and advocacy efforts are essential to improve the prior authorization process.
- Studies indicate that streamlining prior authorizations could allow dermatologists to see more patients daily.
- The AADA and AMA are actively working to reform prior authorization policies to reduce administrative burdens.
- Third-party health care benefit managers often complicate the process of prior authorization, impacting patient access to care.
- Miller T. Christian, Rucker Patrick, Armstrong David. "Not Medically Necessary": Inside the Company Helping America's Biggest Health Insurers Deny Coverage for Care. ProPublica; The Capitol Forum. Oct. 23, 2024, 1:30 p.m. EDT.
- Carlisle Ryan P., Flint Nicholas D., Hopkins Zachary H., Eliason Mark J., Duffin Kristina C., Secrest Aaron M. "Administrative Burden and Costs of Prior Authorizations in a Dermatology Department." JAMA Dermatol. 2020;156(10):1074-1078. doi:10.1001/jamadermatol.2020.1852.
- Popatia Sabrina, Flood Kelsey S., Golbari Nicole M., Patel Parth V., Olbricht Suzanne M., Kimball Alexa B., Porter Martina L. "Examining the Prior Authorization Process, Patient Outcomes, and the Impact of a Pharmacy Intervention: A Single-Center Review." J Am Acad Dermatol 2019;81:1308-18. DOI: 10.1016/j.jaad.2019.05.024.
- Nussbaum Dillon, Kalen Jessica, McCormick Erika, Desai Sapana, Friedman Adam. "Assessing the Impact of Prior Authorizations on Dermatology Residents." Drugs Dermatol. 2024;23(6):485-488. doi:10.36849/JDD.7617.